In a transgenic model of multi-stage squamous carcinogenesis induced by human papillomavirus (HPV) oncogenes, infiltrating CD4+ T cells can be detected in both premalignant and malignant lesions. The lymph nodes that drain sites of epidermal neoplasia contain activated CD4+ T cells predominantly reactive toward Staphylococcal bacterial antigens. HPV16 mice deficient in CD4+ T cells were found to have delayed neoplastic progression and a lower incidence of tumors. This delay in carcinogenesis is marked by decreased infiltration of neutrophils, and reduced activity of matrix metalloproteinase-9, an important cofactor for tumor progression in this model. The data reveal an unexpected capability of CD4 T cells, whereby, proinflammatory CD4+ T cells, apparently responding to bacterial infection of dysplastic skin lesions, can inadvertently enhance neoplastic progression to invasive cancer.
Skip Nav Destination
Article navigation
21 April 2003
Article|
April 14 2003
Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells
Dylan Daniel,
Dylan Daniel
1Department of Biochemistry and Biophysics, Diabetes and Comprehensive Cancer Centers
Search for other works by this author on:
Nicole Meyer-Morse,
Nicole Meyer-Morse
1Department of Biochemistry and Biophysics, Diabetes and Comprehensive Cancer Centers
Search for other works by this author on:
Emily K. Bergsland,
Emily K. Bergsland
2Division of Hematology/Oncology, Department of Medicine
Search for other works by this author on:
Kerstin Dehne,
Kerstin Dehne
3Cancer Research Institute, Department of Pathology, Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA 94143
Search for other works by this author on:
Lisa M. Coussens,
Lisa M. Coussens
3Cancer Research Institute, Department of Pathology, Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA 94143
Search for other works by this author on:
Douglas Hanahan
Douglas Hanahan
1Department of Biochemistry and Biophysics, Diabetes and Comprehensive Cancer Centers
Search for other works by this author on:
Dylan Daniel
1Department of Biochemistry and Biophysics, Diabetes and Comprehensive Cancer Centers
Nicole Meyer-Morse
1Department of Biochemistry and Biophysics, Diabetes and Comprehensive Cancer Centers
Emily K. Bergsland
2Division of Hematology/Oncology, Department of Medicine
Kerstin Dehne
3Cancer Research Institute, Department of Pathology, Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA 94143
Lisa M. Coussens
3Cancer Research Institute, Department of Pathology, Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA 94143
Douglas Hanahan
1Department of Biochemistry and Biophysics, Diabetes and Comprehensive Cancer Centers
Address correspondence to Douglas Hanahan, Diabetes Center, 513 Parnassus Ave., HSW 1090, University of California, San Francisco, San Francisco, CA 94143-0534. Phone: 415-476-9209; Fax: 415-731-3612; E-mail: [email protected]
*
Abbreviations used in this paper: HPV16, human papillomavirus type 16; MMP-9, matrix metalloproteinase-9; SCC, squamous cell carcinoma.
Received:
June 25 2002
Revision Received:
February 21 2003
Accepted:
February 28 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 197 (8): 1017–1028.
Article history
Received:
June 25 2002
Revision Received:
February 21 2003
Accepted:
February 28 2003
Citation
Dylan Daniel, Nicole Meyer-Morse, Emily K. Bergsland, Kerstin Dehne, Lisa M. Coussens, Douglas Hanahan; Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells . J Exp Med 21 April 2003; 197 (8): 1017–1028. doi: https://doi.org/10.1084/jem.20021047
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement